PUBLISHER: The Business Research Company | PRODUCT CODE: 2077713
PUBLISHER: The Business Research Company | PRODUCT CODE: 2077713
Food and drug administration (FDA)-cleared pediatric wearable devices are non-invasive, body-worn medical technologies intended for use in children and adolescents that have undergone regulatory evaluation by the United States Food and Drug Administration to confirm their safety, effectiveness, and intended clinical performance, enabling continuous or intermittent monitoring, diagnosis, or management of physiological parameters in a pediatric population under specified use conditions. These devices are commonly used in clinical and home environments to support early identification of health abnormalities, enable long-term disease management, improve patient monitoring adherence, and provide healthcare professionals and caregivers with actionable physiological data to support informed clinical decision-making.
The primary device types of food and drug administration (FDA)-cleared pediatric wearable devices include pulse oximeters, cardiac monitors or electrocardiogram wearables, respiratory monitors, multi-vital monitors, glucose monitoring wearables, and sleep trackers. Pulse oximeters refer to wearable medical devices used to continuously measure oxygen saturation and pulse rate in pediatric patients for real-time clinical monitoring. These solutions are used for clinical applications such as cardiac monitoring, respiratory monitoring, glucose monitoring, temperature monitoring, and sudden infant death syndrome adjunct monitoring. They utilize technologies such as optical photoplethysmography, electrical electrocardiography, accelerometers, and bio-impedance, while end users include hospitals and neonatal intensive care units, pediatric clinics and outpatient centers, homecare settings and caregivers, and ambulatory surgical centers.
Tariffs are affecting the food and drug administration (FDA)-cleared pediatric wearable devices market by increasing the cost of imported sensors, microelectronics, and semiconductor-based components utilized in wearable monitoring systems. This is resulting in higher device prices and slower adoption across cost-sensitive healthcare systems, particularly in import-dependent regions such as Asia-Pacific and Latin America. Hardware-intensive segments such as multi-vital monitors, cardiac monitoring wearables, and glucose monitoring devices are the most impacted due to global supply chain dependencies and manufacturing concentration in selected countries. However, tariffs are also encouraging local manufacturing initiatives, diversification of supplier networks, and increased investment in domestic medical device production ecosystems, ultimately enhancing long-term supply chain resilience and regional self-sufficiency.
The food and drug administration (FDA)-cleared pediatric wearable devices market research report is one of a series of new reports from The Business Research Company that provides food and drug administration (FDA)-cleared pediatric wearable devices market statistics, including food and drug administration (FDA)-cleared pediatric wearable devices industry global market size, regional shares, competitors with a food and drug administration (FDA)-cleared pediatric wearable devices market share, detailed food and drug administration (FDA)-cleared pediatric wearable devices market segments, market trends and opportunities, and any further data you may need to thrive in the food and drug administration (FDA)-cleared pediatric wearable devices industry. This food and drug administration (FDA)-cleared pediatric wearable devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The food and drug administration (FDA)-cleared pediatric wearable devices market size has grown exponentially in recent years. It will grow from $0.61 billion in 2025 to $0.73 billion in 2026 at a compound annual growth rate (CAGR) of 20.1%. The growth in the historic period can be attributed to increasing prevalence of pediatric chronic diseases, rising demand for early diagnostic interventions, limited availability of child-specific medical wearables, growing hospital-based monitoring dependency, increasing awareness of preventive pediatric healthcare.
The food and drug administration (FDA)-cleared pediatric wearable devices market size is expected to see exponential growth in the next few years. It will grow to $1.52 billion by 2030 at a compound annual growth rate (CAGR) of 20.3%. The growth in the forecast period can be attributed to expansion of home-based pediatric healthcare monitoring, increasing adoption of ai-driven predictive health analytics, rising investment in pediatric digital health infrastructure, growing regulatory approvals for wearable medical devices, increasing integration of cloud and iot healthcare ecosystems. Major trends in the forecast period include rising adoption of ai-enabled pediatric wearable diagnostics for real-time health insights, increasing integration of iot-based connected monitoring ecosystems in pediatric care, expansion of cloud-based remote patient monitoring platforms for children, growing use of advanced biosensor miniaturization for improved wearable accuracy, increasing deployment of cybersecurity frameworks for pediatric health data protection.
The increasing prevalence of chronic pediatric conditions is expected to propel the growth of the FDA-cleared pediatric wearable devices market going forward. Chronic pediatric conditions refer to long-term health disorders affecting infants, children, or adolescents that typically persist for three months or more and often require continuous medical care, ongoing management, and in some cases, lifestyle modifications. Their rising incidence is being driven by multiple contributing factors, including environmental exposures, lifestyle shifts such as increased sedentary behavior and poor dietary habits, as well as enhanced diagnostic capabilities and greater awareness. FDA-cleared pediatric wearable devices, including continuous glucose monitoring systems and cardiac monitoring solutions, support real-time physiological tracking and early identification of complications, thereby enabling proactive disease management and improving treatment adherence. As the burden of chronic conditions continues to rise, healthcare systems, caregivers, and providers are increasingly adopting these technologies, which are supporting better patient outcomes while also helping to reduce long-term healthcare expenditures. For instance, in December 2025, according to the World Health Organization (WHO), a Switzerland-based United Nations (UN) organization, globally, an estimated 35 million children below five years of age were affected by excess weight in 2024, while more than 390 million individuals aged five to nineteen were overweight in 2022, including around 160 million with obesity. Therefore, the growing prevalence of chronic pediatric conditions is contributing to and propelling the growth of the FDA-cleared pediatric wearable devices market.
Leading companies operating in the FDA-cleared pediatric wearable devices market are focusing on innovative advancements such as therapeutic wearable devices to enable non-invasive, personalized treatment solutions. A therapeutic wearable device is a body-worn medical technology designed to deliver targeted therapeutic intervention directly to the user. For example, in June 2025, SoundHealth, a US-based medical technology company specializing in artificial intelligence-driven healthcare solutions, announced U. S. Food and Drug Administration (FDA) approval of SONU Band. The device utilizes artificial intelligence to map sinus structures and deliver customized acoustic vibrations that help reduce nasal inflammation and improve airflow. Its non-invasive, drug-free approach and at-home usability position it as a significant advancement in pediatric respiratory care by enhancing safety and treatment accessibility.
In February 2026, Natus Sensory, a US-based provider of sensory diagnostics, newborn care solutions, and clinical monitoring technologies, acquired TheraB Medical for an undisclosed amount. Through this acquisition, Natus Sensory aims to expand its newborn care portfolio by integrating wearable phototherapy technology, enhancing its therapeutic capabilities and enabling broader delivery of neonatal treatment across hospital and home-care settings. TheraB Medical is a US-based provider of wearable medical devices focused on neonatal jaundice treatment through innovative phototherapy solutions.
Major companies operating in the food and drug administration (fda)-cleared pediatric wearable devices market are Abbott Laboratories, Medtronic plc, Koninklijke Philips N. V. , GE HealthCare Technologies Inc. , Dexcom Inc. , Masimo Corporation, Insulet Corporation, Nihon Kohden Corporation, iRhythm Technologies Inc. , Natus Medical Incorporated, Bittium Corporation, Current Health Ltd. , Sibel Health Inc. , Empatica Inc. , Owlet Baby Care Inc. , LifeSignals Inc. , VitalConnect Inc. , Blue Spark Technologies Inc. , BioIntelliSense Inc. , Nonin Medical Inc. , Biobeat Technologies Ltd. , Lief Therapeutics Inc. , Preventice Solutions Inc.
North America was the largest region in the food and drug administration (FDA)-cleared pediatric wearable devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the food and drug administration (FDA)-cleared pediatric wearable devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the food and drug administration (FDA)-cleared pediatric wearable devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The food and drug administration (FDA)-cleared pediatric wearable devices market consists of sales of products such as temperature monitoring patches, wearable electroencephalography monitoring systems, wearable blood pressure monitoring devices, hydration monitoring wearables, wearable seizure detection devices, posture monitoring wearables, and wearable movement and activity tracking devices for clinical use. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Food And Drug Administration (FDA)-Cleared Pediatric Wearable Devices Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses food and drug administration (fda)-cleared pediatric wearable devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for food and drug administration (fda)-cleared pediatric wearable devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The food and drug administration (fda)-cleared pediatric wearable devices market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.